Price target
2.500.000.00%
The 1 analyst offering 1 year price forecasts for 2616 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to 2616 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
2616 EPS for the last quarter is 0.01 HKD despite the estimation of −0.11 HKD. In the next quarter EPS is expected to reach −0.03 HKD. Track more of CSTONE PHARMACEUTICALS financials and stay on top of what is up with the company.
In the next quarter CSTONE PHARMACEUTICALS revenue is expected to reach 344.45 M HKD. Check out CSTONE PHARMACEUTICALS revenue and earnings and make informed decisions.
According to analysts, 2616 price target is 2.50 HKD with a max estimate of 2.50 HKD and a min estimate of 2.50 HKD. Check if this forecast comes true in a year, meanwhile watch CSTONE PHARMACEUTICALS stock price chart and keep track of the current situation with 2616 news and stock market news.